Dr. Gregg Stanwood
(he/him/his)Associate Professor of Biomedical Sciences & Neuroscience
Faculty
Biomedical Sciences
MSR MC 4340
644-3076
gstanwood@neuro.fsu.edu
- Interest
- We study how genes and environment contribute to the formation and function of brain circuits that mediate cognitive, motivational and emotional responses. Dysregulation of these processes during critical periods of maturation contributes to development of mental health and neurological disorders.
- Current Research
- We primarily work in mouse models of human disease and use pharmacological, behavioral, cell biological, and neuroanatomical methods. In one series of studies we are assessing the roles for dopamine D1 and D2 receptors in the differentiation of forebrain interneurons, and studying how loss and gain of function in the dopamine system leads to neuropsychiatric disorders later in life. In another project, we are focusing on an important insulin regulator in the brain, GLP-1, and how GLP-1 receptors can regulate drug reward, dopamine homeostasis, and responses to stress.
- Recent Publications
-
Delva NC, Stanwood GD (2021). Dysregulation of brain dopamine systems in major depressive disorder. Exp Biol Med, 246(9):1084-1093. PubMed Graham DL, Madkour HS, Noble BL, Schatschneider C, Stanwood GD (2021). Long-term functional alterations following prenatal GLP-1R activation. Neurotoxicol Teratol, 87:106984. PubMed Trammell TS, Henderson NL, Madkour HS, Stanwood GD, Graham DL (2021). GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner. Neurol Sci, 42(7):2911-2919. PubMed Van Lith T, Cheshure A, Pickett SM, Stanwood GD, Beerse M (2021). Mindfulness based art therapy study protocol to determine efficacy in reducing college stress and anxiety. BMC Psychol, 9(1):134. PubMed Graham DL, Durai HH, Trammell TS, Noble BL, Mortlock DP, Galli A, Stanwood GD (2020). A novel mouse model of glucagon-like peptide-1 receptor expression: A look at the brain. J Comp Neurol, 528(14):2445-2470. PubMed Anacker AMJ, Moran JT, Santarelli S, Forsberg CG, Rogers TD, Stanwood GD, Hall BJ, Delpire E, Veenstra-VanderWeele J, Saxe MD (2019). Enhanced Social Dominance and Altered Neuronal Excitability in the Prefrontal Cortex of Male KCC2b Mutant Mice. Autism Res, 12(5):732-743. PubMed Beerse ME, Van Lith T, Pickett SM, Stanwood GD (2019). Biobehavioral utility of mindfulness-based art therapy: Neurobiological underpinnings and mental health impacts. Exp Biol Med (Maywood), 245(2):122-130. PubMed Goldfarb SS, Stanwood GD, Flynn HA, Graham DL (2019). Developmental opioid exposures: Neurobiological underpinnings, behavioral impacts, and policy implications. Exp Biol Med (Maywood), 245(2):131-137. PubMed Davis GL, Stewart A, Stanwood GD, Gowrishankar R, Hahn MK, Blakely RD (2018). Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice. Behav Brain Res, 61-69. PubMed Toki S, Goleniewska K, Reiss S, Zhang J, Bloodworth MH, Stier MT, Zhou W, Newcomb DC, Ware LB, Stanwood GD, Galli A, Boyd KL, Niswender KD, Peebles RS Jr (2018). Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo. J Allergy Clin Immunol, 142(5):1515-1528. PubMed Muller CL, Anacker AM, Rogers TD, Goeden N, Keller EH, Forsberg CG, Kerr TM, Wender C, Anderson GM, Stanwood GD, Blakely RD, Bonnin A, Veenstra-VanderWeele J (2017). Impact of maternal serotonin transporter genotype on placental serotonin, fetal forebrain serotonin, and neurodevelopment. Neuropsychopharmacology, 42(2):427-436. PubMed Martin MM, Graham DL, McCarthy DM, Bhide PG, Stanwood GD (2016). Cocaine-induced neurodevelopmental deficits and underlying mechanisms. Birth Defects Res C Embryo Today, 108(2):147-73. PubMed Reddy IA, Pino JA, Weikop P, Osses N, Sørensen G, Bering T, Valle C, Bluett RJ, Erreger K, Wortwein G, Reyes JG, Graham D, Stanwood GD, Hackett TA, Patel S, Fink-Jensen A, Torres GE, Galli A (2016). Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Transl Psychiatry, 6(5):e809. PubMed
